🔗 Share this article

Given that the United States proceeds with sweeping changes to its vaccine schedules, a particular individual appears somewhat surprisingly: Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who first made her name by casting doubt on COVID-19 vaccinations during the global health crisis and has concentrated on alleged fatalities after COVID-19 immunization in her recent time at the FDA.

Planned Shifts to Pediatric Vaccine Schedule

Public health authorities had intended to announce sweeping changes to the pediatric vaccination calendar recently, synchronizing the US with Denmark’s national calendar, sources say – a substantial departure that would put the US out of step with a large portion of the global community with no evidence for benefit. The announcement has been delayed until the next year.

Instead of Vinay Prasad, Dr. Høeg is set to address the audience at the meeting. She was just designated interim head of the FDA’s CDER, the fifth individual to run the division this calendar year.

A New Direction at the Agency

Høeg's temporary position could signify a strengthened alliance between the drug and biologics centers as Dr. Høeg and Dr. Prasad strengthen their influence at the regulatory agency – and it signals a increased emphasis upon rolling back long-standing immunizations at the FDA.

The new acting director has frequently advocated for ending specific pediatric vaccine recommendations in the US to become more like Denmark, a society with universal health coverage and a population roughly the size of the state of Wisconsin.

To date public appearances, she has persisted in emphasizing on vaccines – typically the domain of Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than drug regulation.

Questions Over Background

Dr. Høeg has no apparent background in drug development, regulation or management, which has been typical for former leaders of the biologics center. She has worked at the FDA as a key advisor to the FDA chief and CBER since earlier this year.

“She doesn’t seem to have the requisite experience” for leading the CDER, said a neurologist and psychiatrist. “She’s never run a scientific study. She is not versed in running a sizeable institution. She lacks background in industry regulation.”

Former commissioners of the center would “grasp legal statutes and the research of medication creation”, said Janet Woodcock. “Frankly, she doesn’t have the sort of resume that prior appointees who ran the center have had.”

The drug center has an immense workload at the agency, the former commissioner emphasized.

“The public just focuses on the new drug program, but the generic drug division clears thousands of generic medications. There’s a biosimilars division, non-prescription drug unit and so forth, and all of those have to be supervised,” Dr. Woodcock said. “The responsibility you don’t keep your eye on, that is precisely what that I always told people is going to cause problems.”

Additionally, a substantial management component to the position, which manages over 5,000 employees. “It’s a huge leadership role, if you perform it correctly,” she added.

Agency Reaction and Contentious Programs

Regarding questions about Høeg’s qualifications and whether this assignment represents greater collaboration among agency officials on vaccines, a spokesperson said that the “questions stem from flawed presumptions”.

“Her experience aligns with the functions of her role,” the representative said, noting the time Dr. Høeg spent counseling the FDA commissioner on “medication safety and regulatory science, including predictive safety algorithms and immunization monitoring”.

In her interim role, Dr. Høeg assumes responsibility for the commissioner’s new expedited review system, a controversial expedited medication authorization process that allegedly troubled her preceding directors. “How are these drugs being selected for this fast-track system? Who is making the calls?” Dr. Howard said. “There’s a lot of confidentiality occurring at the regulatory body right now.”

Broadly speaking, he said, “the Food and Drug Administration appears to be shifting towards laxer oversight of all drugs, except for vaccines.”

Documented Past Work on Immunizations

Regarding vaccines, Dr. Høeg has a more established, if troubling, past, Howard observe. She published a study using unverified volunteer-provided data to estimate the rate of myocarditis following COVID-19 immunization. She counseled the state of Florida surgeon general Joseph Ladapo, who reportedly have changed statistics to indicate COVID-19 vaccinations are more dangerous than they are.

Included in her “wish list” for the incoming administration included revising regulations for recently developed shots and discontinuing “unnecessary” immunizations, she stated post-election on a online show. At the agency, Høeg has reportedly suggested barring adolescent males from obtaining Covid vaccines.

“She’s an complete true believer who commences with her preconceived notions and tailors the evidence to accommodate the science in a extremely deceptive, fraudulent manner,” Howard stated.

Taking Control and a “Campaign of Retribution”

Høeg joined fellow skeptics, {like|